Continuous Glucose Monitor for Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since you need an active prescription for insulin and must inject at least once daily, it seems you will continue using insulin.
What data supports the effectiveness of the treatment Continuous Glucose Monitor for Type 2 Diabetes?
Continuous glucose monitoring (CGM) has been shown to help people with diabetes, including type 2, by providing detailed information about blood sugar patterns, which can lead to better management of their condition. Studies indicate that CGM can improve blood sugar control and reduce the risk of low blood sugar episodes by allowing for timely adjustments in diet and medication.12345
Is continuous glucose monitoring (CGM) safe for humans?
How is the Continuous Glucose Monitor treatment different from other treatments for type 2 diabetes?
The Continuous Glucose Monitor (CGM) is unique because it continuously tracks glucose levels in the body, providing real-time data and alerts for high or low blood sugar, which helps improve glucose control without increasing the risk of hypoglycemia (low blood sugar). Unlike traditional methods that require finger-prick blood tests, CGMs offer a more comprehensive view of glucose patterns, aiding in better diabetes management.15101112
What is the purpose of this trial?
The purpose of this research is to find out if using a continuous glucose monitor and working with a clinical pharmacist can help improve the health of uninsured minority patients with type 2 diabetes.
Research Team
Ryan Larson, PharmD, CPP
Principal Investigator
Myers Park Internal Medicine
Eligibility Criteria
This trial is for uninsured Hispanic or non-Hispanic Black individuals with type 2 diabetes, specifically those who have had an HbA1c level of 8% or higher in the past three months and are currently taking insulin injections at least once a day.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a continuous glucose monitor and pharmacist-led medication management services
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Continuous Glucose Monitor
Continuous Glucose Monitor is already approved in United States, European Union, Canada, Japan for the following indications:
- Type 1 Diabetes
- Type 2 Diabetes
- Insulin-treated Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
American Society of Health System
Collaborator